Recall Register

Food, drugs, devices › Terumo Cardiovascular Systems Corporation

Device recall: CAPIOX RX15 Hollow Fiber Oxygenator, Catalog Number 3CX*RX15RE30

FDA enforcement event 91775 · Class II · initiated 1 Mar 2023 · status Ongoing

DeviceVoluntary: Firm initiated3 product recordsElkton, MD

Terumo Cardiovascular Systems Corporation (Elkton, MD) initiated this device recall on 1 Mar 2023; FDA lists 3 product records under event 91775, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 917 device enforcement events initiated in 2023 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Terumo Cardiovascular Systems Corporation has 73 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Terumo Cardiovascular Systems Corporation, Elkton, MD.

Reason for recall

"Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the arterial thermistor is improperly bonded to the oxygenator port."

Distribution

"US Nationwide. Belgium, Canada, Costa Rica, Thailand."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1345-2023CAPIOX RX15 Hollow Fiber Oxygenator, Catalog Number 3CX*RX15RE301412 unitsClass IIOngoing12 Apr 2023
Z-1346-2023CAPIOX NX19 Hollow Fiber Oxygenator, Catalog Number 3CX*NX19RE84 unitsClass IIOngoing12 Apr 2023
Z-1347-2023CAPIOX FX25 Hollow Fiber Oxygenator, Catalog Numbers 3CX*FX25REC, 3CX*FX25RWC4940 unitsClass IIOngoing12 Apr 2023

Context

88%of 2023 device events are Class II917 events that year
3product records in this eventfirm median: 2
73events on this register for the firm

Other enforcement events for Terumo Cardiovascular Systems Corporation

InitiatedProduct (first record)TypeClassRecords
28 May 2025CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Trial KDeviceClass II1
3 Mar 2025Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754DeviceClass II1
20 Feb 2024Cardiovascular Procedure Kits that include High Crack Check Valve PN 205307A Part Number: 6375 16010 62974 65246 66312 6DeviceClass II1
8 Jun 2021Terumo Advanced Perfusion System 1 Electronic Patient Gas System Catalog #: 801188DeviceClass II1
16 Apr 2021The Terumo HX2 Temperature Management System provides temperature control of two independent water circuits that directlDeviceClass II3
2 Mar 2021Consist of a distal connection mechanism (either standard Terumo Ball Quick Connect or Terumo Shaft Quick Connect), an aDeviceClass II1
11 Nov 2020(1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, Sterile Catalog NuDeviceClass II1
25 Aug 2020Terumo Advanced Perfusion System 1 Ultrasonic Air Sensor 3/8x3/32, Catalog Number 5773 - Product Usage: intended for useDeviceClass II3
10 Jan 2020Terumo Advanced Perfusion System 1 Roller Pump, 4 Inch, Catalog Number 816570 - Product Usage: is indicated for use for DeviceClass II4
14 Jun 2019Terumo Capiox NX19 Oxygenator With Reservoir (East Orientation) P/N: 3CX*NX19REDeviceClass II4

All 73 events for Terumo Cardiovascular Systems Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the arterial thermistor is improperly bonded to the oxygenator port."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide. Belgium, Canada, Costa Rica, Thailand."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.